Aranesp 50 (Darbepoetin Alfa PFS) 40mcg

Aranesp 50 (darbepoetin alfa) is an erythropoiesis-stimulating agent available in a 40mcg prefilled syringe. It supports red blood cell production for patients with certain conditions. Aranesp 50 helps manage anemia linked to chronic kidney disease or chemotherapy. Aranesp 50 is administered under medical supervision for optimal results.

Strength

40mcg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Amgen

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Darbepoetin alfa, the active ingredient in Aranesp 50, is commonly prescribed to address anemia associated with chronic kidney disease or chemotherapy treatment. It stimulates the bone marrow to produce more red blood cells, helping to reduce fatigue and improve energy levels. Aranesp 50 is designed for patients who require long-term management of low red blood cell counts. It is not a cure but helps maintain hemoglobin levels within target ranges.

Side Effects

Patients using Aranesp 50 may notice improved energy and reduced symptoms of anemia over time. The medication works gradually, so noticeable effects typically appear after several weeks of consistent use. Some individuals may experience mild injection-site reactions, such as redness or discomfort. Regular monitoring is recommended to assess response and adjust treatment as needed.

Precautions & Warnings

Aranesp 50 should be stored between 2-8°C and protected from light. It must be handled with care to avoid contamination or damage to the prefilled syringe. Patients should follow their healthcare provider’s instructions for proper administration and disposal. Avoid freezing or shaking the syringe, as this may affect the medication’s efficacy.

Avoid Interactions

Certain medications, such as those that suppress the immune system, may interact with Aranesp 50. Blood pressure medications and iron supplements might also influence its effectiveness. Alcohol and tobacco use can impact overall health and potentially affect treatment outcomes. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Aranesp 50 is used to treat anemia caused by chronic kidney disease or chemotherapy.

Aranesp 50 is given as an injection, typically under the skin, as prescribed by a healthcare provider.

Common side effects may include injection-site reactions, fatigue, or mild headache.

Use during pregnancy should be discussed with a healthcare provider to weigh benefits and risks.

Aranesp 50 should be stored in the refrigerator between 2-8°C and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.